Kimberly Rivers, CEO, Director and 10% Holder, acquired 3,509 Subordinate Voting Shares on a direct ownership basis at prices ranging from US$27.727 to US$28.177 on August 16th, 2021. This represents a $123,083 investment into the company's shares and an account share holdings change of 4.5%.
Alexander D'Amico, a Senior Officer, acquired 660 Subordinate Voting Shares on a direct ownership basis at a price of US$27.000 on August 17th, 2021. This represents a $22,494 investment into the company's shares and an account share holdings change of 30.6%.
Trulieve Cannabis is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
Trulieve Cannabis Corp is a Canada-based medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to dispensaries throughout the State of Florida, as well as to patients via home delivery. It also operates in California, Massachusetts, Connecticut, Pennsylvania and West Virginia. The Company offers a range of products, such as flower, edibles, vaporizer cartridges, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays. It operates cultivation and processing facility in McKeesport, Pennsylvania. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.
No Comments